Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Animal Models

Suppressed apoptosis of pre-B cells in bone marrow of pre-leukemic p190bcr/abl transgenic mice

Abstract

Mice transgenic for a p190bcr/abl construct develop pre-B cell leukemia/lymphoma, providing a model of Ph+ ALL. To investigate events in tumorigenesis, immunofluorescence labeling, flow cytometry and a short-term culture assay were used to quantitate precursor B cells and their apoptotic rates in bone marrow of p190bcr/abl transgenic mice over a wide age range. Malignancies appeared rapidly at 8–12 weeks of age, followed by slower tumor onset. At 8–12 weeks in normal mice, the apoptotic rate fell among pro-B cells but increased steeply among pre-B cells, while the total number of B lineage cells declined. In contrast, in p190bcr/abl transgenic mice over the same time period, while pro-B cells remained normal in apoptotic rate and number, apoptosis of pre-B cells was markedly inhibited and the number of B lymphocytes increased. At later ages (14–30 weeks), B cell precursors in control mice remained constant in apoptotic activity and number, while in the few surviving transgenic mice B cell populations were expanded. The results reveal characteristic changes in apoptotic activity among B cell precursors in bone marrow during early life, severely perturbed in preleukemic p190bcr/abl transgenic mice by a preferential suppression of pre-B cell apoptosis. p190bcr/abl may thus promote leukemogenesis by permitting aberrant cells generated during early B cell development to evade a normal quality checkpoint and negative selection.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 5
Figure 6
Figure 7
Figure 4

Similar content being viewed by others

References

  1. Priest JR, Robison L, Mckenna RW, Lindquist LL, Warkentin PI, LeBien TW, Woods WG, Kersey JH, Coccia PF, Nesbit ME Jr . Philadelphia chromosome positive childhood acute lymphoblastic leukemia Blood 1980 56: 15–22

    CAS  PubMed  Google Scholar 

  2. Ribeiro RC, Abromowitch M, Raimondi SC, Murphy SB, Behm F, Williams DL . Cinical and biologic hallmarks of the Philadelphia chromosome in childhood acute lymphoblastic leukemia Blood 1987 70: 948–953

    CAS  PubMed  Google Scholar 

  3. Bloomfield CD, Secker Walker LM, Goldman AI, Van Den Berghe H, de la Chapelle A, Ruutu T, Alimena G, Garson OM, Golomb HM, Rowley JD, Kaneko Y, Whang-Peng J, Prigogina E, Philip P, Sandberg AA, Lawler SD, Mitelman F . Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia Cancer Genet Cytogenet 1989 40: 171–185

    Article  CAS  Google Scholar 

  4. Melo JV . The molecular biology of chronic myeloid leukaemia Leukemia 1996 10: 751–756

    CAS  PubMed  Google Scholar 

  5. Laneuville P . Abl tyrosine protein kinase Semin Immunol 1995 7: 255–266

    Article  CAS  Google Scholar 

  6. Gotoh A, Broxmeyer HE . The function of BCR/ABL and related proto-oncogenes Curr Opin Hematol 1997 4: 3–11

    Article  CAS  Google Scholar 

  7. Cortez D, Stoica G, Pierce JH, Pendergast AM . The BCR/ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway Oncogene 1996 13: 2589–2594

    CAS  PubMed  Google Scholar 

  8. Sanchez-Garcia I, Martin-Zanca D . Regulation of Bcl-2 gene expression by BCR/ABL is mediated by Ras J Molec Biol 1997 267: 225–228

    Article  CAS  Google Scholar 

  9. Amarante-Mendes GP, Naekyung Kim C, Liu L, Huang Y, Perkins CL, Green DR, Bhalla K . Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3 Blood 1998 91: 1700–1705

    CAS  PubMed  Google Scholar 

  10. Amarante-Mendes GP, McGahon AJ, Nisioka WK, Afar DE, Witte ON, Green DR . Bcl-2-independent Bcr/Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL Oncogene 1998 16: 1383–1390

    Article  CAS  Google Scholar 

  11. Dubrez L, Eymin B, Sordet O, Droin N, Turhan AG, Solary E . BCR/ABL delays apoptosis upstream of procaspase-3 Blood 1998 91: 2415–2422

    CAS  PubMed  Google Scholar 

  12. Heisterkamp N, Jenster G, ten Hoeve J, Zovich D, Pattengale PK, Groffen J . Acute leukaemia in bcr/abl transgenic mice Nature 1990 344: 251–253

    Article  CAS  Google Scholar 

  13. Griffiths SD, Healy LE, Ford AM, Bennett CA, Voncken JW, Heisterkamp N, Groffen J, Greaves MF . Clonal characteristics of acute lymphoblastic cells derived from BCR/ABL p190 transgenic mice Oncogene 1992 7: 1391–1399

    CAS  PubMed  Google Scholar 

  14. Voncken JW, Griffiths S, Greaves MF, Pattengale PK, Heisterkamp N, Groffen J . Restricted oncogenicity of BCR/ABL p190 in transgenic mice Cancer Res 1992 52: 4534–4539

    CAS  PubMed  Google Scholar 

  15. Voncken JW, Kaartinen V, Pattengale PK, Germeraad WTV, Groffen J, Heisterkamp N . BCR/ABL p210 and 190 cause distinct leukemia in transgenic mice Blood 1995 85: 4603–4611

    Google Scholar 

  16. Osmond DG, Rico-Vargas S, Valenzona H, Fauteux L, Liu L, Janani R, Lu L, Jacobsen K . Apoptosis and macrophage-mediated cell deletion in the regulation of B lymhopoiesis in mouse bonemarrow Immunol Rev 1994 142: 209–230

    Article  CAS  Google Scholar 

  17. Lu L, Osmond DG . Apoptosis during B lymphopoiesis in mouse bone marrow J Immunol 1997 158: 5136–5145

    CAS  PubMed  Google Scholar 

  18. Osmond DG, Rolink A, Melchers F . Murine B lymphopoiesis: towards a unified model Immunol Today 1998 19: 65–68

    Article  CAS  Google Scholar 

  19. Melchers F, Rolink A, Grawunder U, Winkler TH, Karasuyama H, Gia P, Andersson J . Positive and Negative selection events during B lymphopoiesis Curr Opin Immunol 1995 7: 214–227

    Article  CAS  Google Scholar 

  20. Rajewsky K . Clonal selection and learning in the antibody system Nature 1996 381: 751–758

    Article  CAS  Google Scholar 

  21. Voncken JW, Morris C, Pattengale P, Dennert G, Kikly C, Groffen J, Heisterkamp N . Clonal development and karyotype evolution during leukemogenesis of BCR/ABL transgenic mice Blood 1992 79: 1029–1036

    CAS  PubMed  Google Scholar 

  22. Winkler TH, Rolink A, Melchers F, Harasuyama H . Precursor B cells of mouse bone marrow express two different complexes with surrogate light chain on the surface Eur J Immunol 1995 25: 446–450

    Article  CAS  Google Scholar 

  23. Li YS, Wasserman R, Hayakawa K, Hardy RR . Identification of the earliest B lineage stage in mouse bone marrow Immunity 1996 5: 527–535

    Article  CAS  Google Scholar 

  24. Rolink A, ten Boekel E, Melchers F, Fearon DT, Krop I, Andersson J . A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors J Exp Med 1996 183: 187–194

    Article  CAS  Google Scholar 

  25. Miller SC, Osmond DG . Lymphocyte populations in mouse bone marrow. Quantitative kinetic studies in young, pubertal and adult C3H mice Cell Tissue Kinet 1975 8: 97–110

    CAS  PubMed  Google Scholar 

  26. Nowell PC . The clonal evolution of tumor cell populations Science 1976 194: 23–28

    Article  CAS  Google Scholar 

  27. Tsujimoto Y, Gorham J, Cossman J, Jaffee E, Croce CM . The t(14,18) chromosome translocation involved in B cell neoplasms result from mistakes in VDJ joining Science 1985 229: 1390–1393

    Article  CAS  Google Scholar 

  28. Lewis SM . The mechanism of V(D)J joining: lessons from molecular, immunological, and comparative analyses Adv Immunol 1994 56: 27–150

    Article  CAS  Google Scholar 

  29. Lu L, Lejtenyi D, Osmond DG . Regulation of cell survival during B lymphopoiesis: suppressed apoptosis of pro-B cells in P53-deficient mouse bone marrow Eur J Immunol 1999 29: 2484–2490

    Article  CAS  Google Scholar 

  30. Schwartzberg PL, Stall AM, Hardin JD, Bowdish KS, Humaran T, Boast S, Harbison ML, Robertson EJ, Goff SP . Mice homozygous for the ablml mutation show poor viability and depletion of selected B and T cell populations Cell 1991 65: 1165–1175

    Article  CAS  Google Scholar 

  31. Chen Q, Takeyama N, Brady G, Watson AJ, Dive C . Blood cells with reduced mitochondrial membrane potential and cytosolic cytochrome C can survive and maintain clonogenicity given appropriate signals to suppress apoptosis Blood 1998 92: 4545–4553

    CAS  PubMed  Google Scholar 

  32. Dan S, Naito M, Tsuruo T . Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR-ABL tyrosine kinase, CGP57148 Cell Death Differ 1998 5: 710–715

    Article  CAS  Google Scholar 

  33. Lu L, Chaudhury P, Osmond DG . Regulation of cell survival during B lymphopoiesis: apoptosis and Bcl-2/Bax content of precursor B cells in bone marrow of mice with altered expression of IL-7 and recombinase-activating gene-2 J Immunol 1999 162: 1931–1940

    CAS  PubMed  Google Scholar 

  34. Janani R, Harris AW, Strasser A, Dhanoa S, Plyam R, Osmond DG . Effect of a bcl-2 transgene on production and localization of precursor B cells in mouse bone marrow Exp Hematol 1998 26: 982–990

    CAS  PubMed  Google Scholar 

  35. Malek SN, Dordai DI, Reim J, Dintzis H, Desiderio S . Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase Proc Natl Acad Sci USA 1998 95: 7351–7356

    Article  CAS  Google Scholar 

  36. Sidman CL, Shaffer DJ, Jacobsen K, Rico-Vargas S, Osmond DG . Cell populations during tumorigenesis in Eμ-myc transgenic mice Leukemia 1993 7: 887–895

    CAS  PubMed  Google Scholar 

  37. Valenzona HO, Pointer R, Ceredig R, Osmond DG . Prelymphomatous B cell hyperplasia in the bone marrow of interleukin-7 transgenic mice: precursor B cell dynamics, microenvironmental organization and osteolysis Exp Hematol 1996 24: 1521–1529

    CAS  PubMed  Google Scholar 

  38. Laneuville P, Sun G, Timm M, Vekemans M . Clonal evolution in a myeloid cell line transformed to interleukin-3 independent growth by retroviral transduction and expression of p210 bcr/abl Blood 1992 80: 1788–1797

    CAS  PubMed  Google Scholar 

  39. Kitamura D, Kudo A, Schaal S, Muller W, Melchers F, Rajewsky K . A critical role of λ5 protein in B cell development Cell 1992 69: 823–831

    Article  CAS  Google Scholar 

  40. Kincade PW . Molecular interactions between stromal cells and B lymphocyte precursors Semin Immunol 1991 3: 379–390

    CAS  PubMed  Google Scholar 

  41. Fauteux LJ, Osmond DG . IL-1 as systemic modifier of B lymphopoiesis. Recombinant IL-1 alpha binds to stromal cells and sinusoid endothelium in bone marrow and perturbs precursor B cell dynamics J Immunol 1996 156: 2376–2383

    CAS  PubMed  Google Scholar 

  42. McWhirter JR, Wang JYL . An actin-binding function contributes to transformation by the bcr/abl oncoprotein of Philadelphia chromosome-positive human leukemia EMBO J 1993 12: 1533–1546

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the Medical Research Council of Canada and the National Cancer Institute of Canada with funds from the Canadian Cancer Society.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, Q., Brain, J., Laneuville, P. et al. Suppressed apoptosis of pre-B cells in bone marrow of pre-leukemic p190bcr/abl transgenic mice. Leukemia 15, 819–827 (2001). https://doi.org/10.1038/sj.leu.2402079

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402079

Keywords

This article is cited by

Search

Quick links